Eli Lilly and Merck & Co. are partnering with Purdue University to launch the Young Institute Pharmaceutical Manufacturing ...

Lilly's stock went on a tear in the beginning of 2023, with the company's shares doubling as investors bet on the drug's popularity. The stock stumbled in October last year, after Zepbound's sales ...

Eli Lilly and Co., which cemented ... The Boston biotech is going to spin out a new company to hold its employees and develop its non-PI3Kα pipeline drugs. The new company will be independent ...